Evidence map›Paper›PMID 39814071›Full record

ArticleNature2025

Engineered enzymes for enantioselective nucleophilic aromatic substitutions.

Thomas M Lister, George W Roberts, Euan J Hossack, Fei Zhao, Ashleigh J Burke, Linus O Johannissen, Florence J Hardy, Alexander A V Millman, David Leys, Igor Larrosa and 1 more

Abstract read
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Designing Enzymatic Reactivity with an Expanded Palette.Chembiochem : a European journal of chemical biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Thomas M ListerManchester Institute of Biotechnology, The University of Manchester, Manchester, UK.ORCID 0000-0002-6677-2797
George W RobertsManchester Institute of Biotechnology, The University of Manchester, Manchester, UK.
Euan J HossackManchester Institute of Biotechnology, The University of Manchester, Manchester, UK.
Fei ZhaoManchester Institute of Biotechnology, The University of Manchester, Manchester, UK.ORCID 0000-0003-1841-4466
Ashleigh J BurkeManchester Institute of Biotechnology, The University of Manchester, Manchester, UK.
Linus O JohannissenManchester Institute of Biotechnology, The University of Manchester, Manchester, UK.ORCID 0000-0002-0916-9094
Florence J HardyManchester Institute of Biotechnology, The University of Manchester, Manchester, UK.
Alexander A V MillmanDepartment of Chemistry, The University of Manchester, Manchester, UK.ORCID 0000-0002-0843-4722
David LeysManchester Institute of Biotechnology, The University of Manchester, Manchester, UK.ORCID 0000-0003-4845-8443
Igor LarrosaDepartment of Chemistry, The University of Manchester, Manchester, UK. igor.larrosa@manchester.ac.uk.ORCID 0000-0002-5391-7424
Anthony P GreenManchester Institute of Biotechnology, The University of Manchester, Manchester, UK. anthony.green@manchester.ac.uk.ORCID 0000-0003-0454-1798

Funding

EPSRCEuropean Research Council
6 · The paper itself

Abstract

Nucleophilic aromatic substitutions (S

Indexed as

BiocatalysisProtein EngineeringArginineCatalytic DomainDirected Molecular EvolutionModels, MolecularStereoisomerismSubstrate SpecificityArginine

Identifiers

PMID39814071
PMCPMC11903332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.